PubMed for id: 865

Year	Number of Results
1988	1
1993	1
1994	1
1995	1
1996	2
1997	2
1998	3
1999	2
2000	3
2001	2
2002	5
2004	7
2005	4
2006	3
2007	4
2008	3
2009	7
2010	9
2011	7
2012	10
2013	12
2014	21
2015	14
2016	6
2017	14
2018	8
2019	9
2020	11
2021	12
2022	10
2023	7
2024	0

1

Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.

Hsu CH, Ma HP, Ong JR, Hsieh MS, Yadav VK, Yeh CT, Chao TY, Lee WH, Huang WC, Kuo KT, Fong IH, Lin CC, Su CM. Hsu CH, et al. Dis Markers. 2022 Jul 19;2022:8446629. doi: 10.1155/2022/8446629. eCollection 2022. Dis Markers. 2022. PMID: 35903297 Free PMC article.

2

3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant.

Tang G, Zou Y, Wang SA, Borthakur G, Toruner G, Hu S, Li S, Xu J, Medeiros LJ, Tang Z. Tang G, et al. Ann Hematol. 2022 Apr;101(4):847-854. doi: 10.1007/s00277-022-04767-1. Epub 2022 Feb 20. Ann Hematol. 2022. PMID: 35184217

3

Mori A, Onozawa M, Hidaka D, Yokoyama S, Miyajima T, Yokoyama E, Ogasawara R, Izumiyama K, Saito M, Fujisawa S, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Nagashima T, Iwasaki H, Kobayashi H, Haseyama Y, Kurosawa M, Morioka M, Teshima T, Kondo T. Mori A, et al. Int J Hematol. 2022 Feb;115(2):188-197. doi: 10.1007/s12185-021-03238-z. Epub 2021 Nov 5. Int J Hematol. 2022. PMID: 34739701

4

Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure.

Ustun C, Morgan EA, Ritz EM, Vestergaard H, Pullarkat S, Kluin PM, Ohgami R, Baughn LB, Kim Y, Ku NK, Czuchlewski D, Boe Møller M, Schiefer AI, Mrózek K, Horny HP, George TI, Kielsgaard Kristensen T, Beck T, Nathan S, Arana Yi C, Yeung C, Pullarkat V, Gotlib J, Akin C, Kohlschmidt J, Salhotra A, Soma L, Chen D, Han SY, Cho C, Sperr W, Broesby-Olsen S, Linden MA, Dolan M, Hoermann G, Hornick JL, Bloomfield C, Nakamura R, Joachim Deeg H, Litzow MR, Borthakur G, Weisdorf D, Huls G, Perales MA, Valent P, Marcucci G. Ustun C, et al. Int J Lab Hematol. 2021 Feb;43(1):e19-e25. doi: 10.1111/ijlh.13338. Epub 2020 Sep 14. Int J Lab Hematol. 2021. PMID: 32926565 Free PMC article. No abstract available.

5

The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.

Guo L, Chen B, Zhang G, Wang Y, Cao L, Ren C, Wen L, Lin J, Wei G, Liao N. Guo L, et al. Gene. 2020 Oct 30;759:144970. doi: 10.1016/j.gene.2020.144970. Epub 2020 Jul 22. Gene. 2020. PMID: 32711101

6

Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB.

van Bergen MGJM, Saes JL, Simons A, Hebeda KM, Henskens YMC, Barteling W, Huys E, Laros-van Gorkom BAP, Schols SEM, Preijers FW, Jongmans MCJ, Jansen JH, van der Reijden BA. van Bergen MGJM, et al. Am J Hematol. 2020 Jun;95(6):E136-E139. doi: 10.1002/ajh.25770. Epub 2020 Apr 8. Am J Hematol. 2020. PMID: 32124467 Free PMC article. No abstract available.

7

A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells.

Ran R, Harrison H, Syamimi Ariffin N, Ayub R, Pegg HJ, Deng W, Mastro A, Ottewell PD, Mason SM, Blyth K, Holen I, Shore P. Ran R, et al. Oncogene. 2020 Mar;39(12):2624-2637. doi: 10.1038/s41388-020-1170-2. Epub 2020 Jan 31. Oncogene. 2020. PMID: 32005976 Free PMC article.

8

Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx.

Xu F, Song H, Xiao Q, Li N, Zhang H, Cheng G, Tan G. Xu F, et al. Cell Mol Immunol. 2019 Apr;16(4):357-366. doi: 10.1038/s41423-018-0006-2. Epub 2018 Mar 9. Cell Mol Immunol. 2019. PMID: 29523836 Free PMC article.

9

D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia.

Omori I, Yamaguchi H, Miyake K, Miyake N, Kitano T, Inokuchi K. Omori I, et al. Exp Hematol. 2017 Aug;52:56-64.e4. doi: 10.1016/j.exphem.2017.05.003. Epub 2017 May 12. Exp Hematol. 2017. PMID: 28506695 Free article.

10

CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis.

Cordonnier G, Mandoli A, Radhouane A, Hypolite G, Lhermitte L, Belhocine M, Asnafi V, Macintyre E, Martens JHA, Fumagalli S, Bond J. Cordonnier G, et al. Leukemia. 2017 Jun;31(6):1443-1446. doi: 10.1038/leu.2017.53. Epub 2017 Feb 15. Leukemia. 2017. PMID: 28196984 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year